BioMatrix Infusion Pharmacy, which is backed by Frazier Healthcare Partners, has acquired Lux Infusion, an Anchorage, ...

The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination developed by SQ Innovation, Inc., for treating edema caused by chronic heart ...

AIC, a division of AIS Healthcare, now offers YIMMUGO®, manufactured by Kedrion Biopharma, for the treatment of primary humoral immunodeficiency in patients 2 years of age and older.

Ohio’s health care system relies on outpatient infusion care, a vital service for patients managing complex conditions such ...

Through the integration of LUX Infusion, BioMatrix strengthens its national platform in several key ways: Expand Our Reach: Adds three premier infusion centers in Alaska, advancing BioMatrix’s ability ...